Serial Number:
87924207
Mark:
DICERNA PHARMACEUTICALS
Status:
Abandoned-No Statement of Use filed
Status Date:
01-31-2022
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Mark Description:
The mark consists of a vertical double helix positioned to the left of the words "DICERNA PHARMACEUTICALS". The word "DICERNA" is stacked directly above the word "PHARMACEUTICALS". A left pointing arrow head is positioned at the base of the letter "D" of "DICERNA", splicing the double helix.
Class:
Scientific and technological services
Type of Mark:
Trademark
Published for Opposition Date:
10-30-2018
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
01-31-2022
Business Name:
PANITCH SCHWARZE BELISARIO & NADEL LLP
Correspondent Name:
